Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for High-Pressure Homogenization for Nanoparticle Production

Posted on By

SOP for High-Pressure Homogenization for Nanoparticle Production

Standard Operating Procedure for High-Pressure Homogenization in Nanoparticle Production

1) Purpose

This SOP outlines the high-pressure homogenization method used for reducing particle size in nanoparticle production, a technique commonly employed to achieve nanoparticles for drug delivery and other applications.

2) Scope

This SOP applies to all operators using high-pressure homogenizers to reduce the particle size of nanoparticles in formulations.

3) Responsibilities

  • Operators: Responsible for setting up and operating the high-pressure homogenizer.
  • QA: Ensures the final nanoparticles meet quality and size specifications.

4) Procedure

4.1 Preparation of Sample

4.1.1 Sample Preparation

  • 4.1.1.1 Prepare the nanoparticle suspension as per formulation guidelines, ensuring that the starting particle size is suitable for homogenization.
  • 4.1.1.2 Transfer the suspension into the homogenizer feed tank.
See also  SOP for Preparation of Nanoparticles for Gene Delivery

4.2 High-Pressure Homogenization

4.2.1 Equipment Setup

  • 4.2.1.1 Calibrate the high-pressure homogenizer according to the manufacturer’s instructions.
  • 4.2.1.2 Set the operating pressure between 500 and 1500 bar, depending on the formulation needs.

4.2.2 Particle Size Reduction

  • 4.2.2.1 Pass the nanoparticle suspension through the homogenizer for multiple cycles (usually 3–5 passes) until the desired particle size is achieved.
  • 4.2.2.2 Monitor the particle size during the process using dynamic light scattering (DLS) or a similar technique.

4.3 Cleaning and Maintenance

4.3.1 Cleaning of Equipment

  • 4.3.1.1 Clean the homogenizer thoroughly after each batch using sterile water and a cleaning solution to remove any residual particles or contaminants.
See also  Nanoparticle Formulation : SOP for Preparation of Nanoparticles for Transdermal Delivery

4.4 Storage of Nanoparticles

4.4.1 Storage Conditions

  • 4.4.1.1 Store the nanoparticle suspension in sealed, sterile containers at 4°C, or freeze-dry for long-term storage if necessary.

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering
  • QA: Quality Assurance

6) Documents, if any

  • High-Pressure Homogenization Process Logbook

7) References, if any

  • Manufacturer’s instructions for high-pressure homogenizer

8) SOP Version

Version 1.0

Annexure

High-Pressure Homogenization Process Logbook Template

Date Batch Number Pressure (bar) Particle Size Encapsulation Efficiency Operator Initials QA Initials
DD/MM/YYYY Batch Number Pressure Used (e.g., 1000 bar) Size in nm % Encapsulation Operator Name QA Name
           
Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

Post navigation

Previous Post: SOP for Preparation of Buffers for Lyophilized Formulations
Next Post: SOP for Ensuring Microbial Stability in Nasal Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version